Q4 2024 · 13F-HR
Parkman Healthcare Partners LLCholdings as filed
Filed 2025-02-14 · accession 0001420506-25-000552
$750.9M
Reported value
89
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 375558103 | GILD | GILEAD SCIENCES INC | $34.6M | 4.61% | 374,825 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $33.5M | 4.46% | 720,657 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $32.8M | 4.37% | 125,761 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $30.1M | 4.01% | 337,354 | Common | SOLE |
| 863667101 | SYK | STRYKER CORPORATION | $28.0M | 3.73% | 77,717 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $25.2M | 3.36% | 274,569 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $21.7M | 2.90% | 28,163 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $20.8M | 2.78% | 1,087,634 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $20.3M | 2.70% | 243,123 | Common | SOLE |
| 56400P706 | MNKD | MANNKIND CORP | $20.1M | 2.68% | 3,126,727 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $20.0M | 2.67% | 176,994 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $19.5M | 2.59% | 1,117,792 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $19.0M | 2.53% | 1,273,789 | Common | SOLE |
| 075887109 | BDX | BECTON DICKINSON & CO | $16.0M | 2.13% | 70,404 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $15.8M | 2.10% | 115,727 | Common | SOLE |
| G52694109 | KNSA | KINIKSA PHARMACEUTICALS INTL | $15.1M | 2.02% | 765,453 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $13.6M | 1.82% | 90,352 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $13.5M | 1.80% | 106,987 | Common | SOLE |
| 91307C102 | UTHR | UNITED THERAPEUTICS CORP DEL | $13.2M | 1.76% | 37,472 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $13.1M | 1.75% | 23,000 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS I | $12.7M | 1.69% | 1,000,474 | Common | SOLE |
| N72482149 | — | QIAGEN NV | $12.3M | 1.64% | 277,272 | Common | SOLE |
| 126638105 | CVRX | CVRX INC | $11.7M | 1.55% | 921,174 | Common | SOLE |
| 80810D103 | SDGR | SCHRODINGER INC | $10.9M | 1.45% | 563,091 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $10.8M | 1.43% | 145,214 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $10.5M | 1.40% | 869,759 | Common | SOLE |
| 78349D107 | RXST | RXSIGHT INC | $10.3M | 1.38% | 300,698 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $10.2M | 1.36% | 381,173 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $10.1M | 1.35% | 20,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $10.0M | 1.34% | 532,172 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $9.5M | 1.27% | 116,138 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $9.1M | 1.21% | 38,672 | Common | SOLE |
| 14843C105 | CSTL | CASTLE BIOSCIENCES INC | $8.1M | 1.08% | 304,629 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $8.1M | 1.08% | 174,934 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $8.1M | 1.08% | 180,000 | Common | SOLE |
| 69366J200 | PTCT | PTC THERAPEUTICS INC | $8.0M | 1.07% | 177,368 | Common | SOLE |
| 219798105 | QDEL | QUIDELORTHO CORP | $7.8M | 1.04% | 175,415 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $7.6M | 1.01% | 193,004 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $7.4M | 0.98% | 784,376 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $7.0M | 0.93% | 526,973 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $6.1M | 0.81% | 78,550 | Common | SOLE |
| 05463X106 | AXGN | AXOGEN INC | $6.0M | 0.80% | 365,703 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $5.0M | 0.66% | 314,541 | Common | SOLE |
| 088786108 | BCYC | BICYCLE THERAPEUTICS PLC | $4.9M | 0.66% | 352,481 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $4.9M | 0.65% | 275,000 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $4.6M | 0.62% | 37,751 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $4.6M | 0.61% | 829,105 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $4.3M | 0.58% | 196,805 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $4.2M | 0.56% | 100,159 | Common | SOLE |
| 92337F107 | VCYT | VERACYTE INC | $4.0M | 0.53% | 100,301 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $3.9M | 0.52% | 77,223 | Common | SOLE |
| M96088105 | URGN | UROGEN PHARMA LTD | $3.9M | 0.52% | 369,861 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $3.9M | 0.51% | 85,000 | Common | SOLE |
| 71377E105 | PFMTUSD | PERFORMANT HEALTHCARE INC | $3.8M | 0.51% | 1,257,805 | Common | SOLE |
| 29772L108 | ETON | ETON PHARMACEUTICALS INC | $3.7M | 0.49% | 276,890 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $3.4M | 0.45% | 44,492 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $3.4M | 0.45% | 491,080 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $3.3M | 0.44% | 15,874 | Common | SOLE |
| 869367102 | — | SUTRO BIOPHARMA INC | $3.2M | 0.42% | 1,727,925 | Common | SOLE |
| 55287L101 | MBX | MBX BIOSCIENCES INC | $3.1M | 0.42% | 170,000 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $3.0M | 0.40% | 216,600 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $2.9M | 0.39% | 54,294 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $2.8M | 0.38% | 220,980 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $2.6M | 0.35% | 51,133 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $2.5M | 0.33% | 35,668 | Common | SOLE |
| 124155102 | BFLY | BUTTERFLY NETWORK INC | $2.3M | 0.31% | 750,000 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $2.2M | 0.30% | 854,716 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $2.1M | 0.28% | 228,334 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $2.1M | 0.27% | 500,548 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $2.0M | 0.27% | 106,871 | Common | SOLE |
| 53228F101 | LFST | LIFESTANCE HEALTH GROUP INC | $2.0M | 0.27% | 277,471 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $2.0M | 0.26% | 578,511 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $2.0M | 0.26% | 76,116 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $1.9M | 0.26% | 45,680 | Common | SOLE |
| 56600D107 | MRVI | MARAVAI LIFESCIENCES HLDGS I | $1.9M | 0.25% | 350,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $1.8M | 0.25% | 23,588 | Common | SOLE |
| 46333X108 | IRWD | IRONWOOD PHARMACEUTICALS INC | $1.8M | 0.24% | 408,535 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.7M | 0.23% | 330,849 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $1.7M | 0.22% | 125,000 | Common | SOLE |
| 09058V103 | BCRX | BIOCRYST PHARMACEUTICALS INC | $1.6M | 0.22% | 216,881 | Common | SOLE |
| 745848101 | LUNG | PULMONX CORP | $1.4M | 0.19% | 207,853 | Common | SOLE |
| 76152G100 | — | REVIVA PHARMACEUTCLS HLDGS I | $930,834 | 0.12% | 514,273 | Common | SOLE |
| 039697107 | ARDX | ARDELYX INC | $901,416 | 0.12% | 177,794 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO INC | $892,215 | 0.12% | 86,707 | Common | SOLE |
| M40527109 | ENTX | ENTERA BIO LTD | $877,112 | 0.12% | 413,732 | Common | SOLE |
| 15678C102 | CBLL | CERIBELL INC | $828,212 | 0.11% | 32,002 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $522,884 | 0.07% | 290,491 | Common | SOLE |
| 92941V308 | VYNE | VYNE THERAPEUTICS INC | $512,460 | 0.07% | 152,973 | Common | SOLE |
| 268311107 | EDAP | EDAP TMS S A | $342,179 | 0.05% | 154,832 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.